Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis

Hepatogastroenterology. 2012 Jun;59(116):1217-9. doi: 10.5754/hge09739.

Abstract

Background/aims: The correlation between the mass-forming type of intrahepatic cholangiocarcinoma (ICC) and the infection of the hepatitis B virus and hepatitis C virus are poorly understood. In this study, the clinical features of 34 patients with the mass-forming type ICC were reviewed to evaluate prognostic determinants.

Methodology: Between January 1997 and December 2007, 34 patients underwent surgical resection for the mass-forming type of ICC in Kumamoto University Hospital. The significance of 14 clinicopathological factors consisting of age, gender, CA19-9 levels, CEA levels, size, intrahepatic metastases, portal vein invasion, bile duct invasion, histological differentiation, lymph node involvement, type B or C hepatitis, lymph node dissection, Sirius Red score of the tumor and platelet count in peripheral blood were analyzed, with regard to prognostic aspect.

Results: Univariate analysis showed that significant risk factors for poor survival included age =65 years, CEA levels =1.6ng/mL and pathological lymph node involvement. Multivariate analysis revealed that age, CEA levels and lymph node involvement were independent and significant poor prognostic factors.

Conclusions: It was concluded that age, CEA levels and lymph node involvement were significantly poor prognostic factors. However, the infection with type B or C hepatitis was not a prognostic factor of the mass forming type ICC.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms
  • Bile Ducts, Intrahepatic
  • CA-19-9 Antigen / blood
  • Carcinoembryonic Antigen / blood
  • Cholangiocarcinoma / blood
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / pathology*
  • Female
  • Humans
  • Length of Stay
  • Liver / physiopathology
  • Liver Neoplasms / blood
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Proportional Hazards Models

Substances

  • CA-19-9 Antigen
  • Carcinoembryonic Antigen